Alpha-1 MP
AssetAlso Alpha1-Proteinase Inhibitor (Human), Modified Process
Human alpha-1 proteinase inhibitor augmentation therapy inhibiting neutrophil elastase to protect lung tissue.
- Stage
- Phase 3
- Modality
- Protein or enzyme
- Target
- Proteostasis
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Pulmonary emphysema in Alpha-1 PI deficiency
Phase 3, Completed, NCT01983241, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors1
Every asset’s record: target, stage, trials and the evidence behind it.